HUP0401808A2 - Dosage forms, devices and methods of treatment - Google Patents
Dosage forms, devices and methods of treatmentInfo
- Publication number
- HUP0401808A2 HUP0401808A2 HU0401808A HUP0401808A HUP0401808A2 HU P0401808 A2 HUP0401808 A2 HU P0401808A2 HU 0401808 A HU0401808 A HU 0401808A HU P0401808 A HUP0401808 A HU P0401808A HU P0401808 A2 HUP0401808 A2 HU P0401808A2
- Authority
- HU
- Hungary
- Prior art keywords
- rumen
- amounts
- predetermined
- ruminant
- active substance
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- 239000002552 dosage form Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 8
- 210000004767 rumen Anatomy 0.000 abstract 6
- 241000282849 Ruminantia Species 0.000 abstract 4
- 239000013543 active substance Substances 0.000 abstract 4
- 238000009472 formulation Methods 0.000 abstract 3
- 241001465754 Metazoa Species 0.000 abstract 2
- 230000003111 delayed effect Effects 0.000 abstract 2
- 239000003463 adsorbent Substances 0.000 abstract 1
- 238000013270 controlled release Methods 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000012530 fluid Substances 0.000 abstract 1
- 238000003780 insertion Methods 0.000 abstract 1
- 230000037431 insertion Effects 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 230000014759 maintenance of location Effects 0.000 abstract 1
- 230000000541 pulsatile effect Effects 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0068—Rumen, e.g. rumen bolus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/14—Ectoparasiticides, e.g. scabicides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Tropical Medicine & Parasitology (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Inorganic Chemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
A jelen találmány kérődző állatok bendőjébe való inzertáláshoz és abendőben tartáshoz adaptált szabályozott dózisfelszabadítású elemmelkapcsolatos. Az elem a következőket tartalmazza: a) legalább egy elsőaktív anyagot tartalmazó legalább egy első készítmény egy vagy többkülönálló és előre meghatározott mennyiségét, ahol a készítményt abendő folyadékokban való olyan sebességgel történő feloldódáshozadaptálták, amelynek során az első készítmény egy vagy több mennyiségeaz első aktív anyag rövid idejű vagy pulzáló epizódokban történőfelszabadulását eredményezi a bendőbe; és b) legalább egy másodikolyan készítmény egy vagy több előre meghatározott mennyiségét,amelyet a bendő folyadékokban való szabályozott felszabaduláshozadaptálnak, ahol az első készítmény egy vagy több mennyiségét azelemen belül egy vagy több előre meghatározott helyen biztosítják amásodik készítmény említett egy vagy több mennyiségéhez képest alegalább első aktív anyag bendőben történő előre meghatározottidőpontokban történő egy vagy több késleltetett felszabadulásához, egyelőre meghatározott hosszabb időszak előtt, alatt vagy után, vagy ezektetszőleges kombinációjában, amit az említett második készítményhatároz meg. A jelen találmány kapcsolatos legalább az első aktívanyag kérődző állat bendőjébe késleltetett módon történő bejuttatásimódszerével is, egy vagy több előre meghatározott időpontban, miutánaz állatnak az aktív anyagot tartalmazó készítményt beadták, és azeljárás magába foglalja a jelen találmány szerinti szabályozott dózisfelszabadítású elem állatnak való beadását. Az első aktív anyagtipikusan egy beteg vagy fertőzött kérődző állat kezelésre, vagybetegségének megelőzésre szolgál, vagy mindkét célból használható,vagy alkalmazható a kérődző állat fiziológiai státuszánakmegváltoztatására. ÓThe present invention relates to a controlled dose release element adapted for insertion into the rumen of ruminant animals and for retention in the rumen. The element comprises: a) one or more discrete and predetermined amounts of at least one first composition containing at least one first active substance, where the composition is adapted to dissolve in adsorbent liquids at a rate during which one or more amounts of the first composition are short-term or results in its release into the rumen in pulsatile episodes; and b) at least one or more predetermined amounts of a second formulation adapted for controlled release in rumen fluids, wherein one or more amounts of the first formulation are provided at one or more predetermined locations within the element in relation to said one or more amounts of the second formulation at least first active for one or more delayed release of a substance in the rumen at predetermined times, before, during or after a predetermined longer period, or in any combination thereof, which is determined by said second composition. The present invention is also related to a method of introducing at least the first active substance into the rumen of a ruminant animal in a delayed manner, at one or more predetermined times after the animal has been administered the composition containing the active substance, and the method includes administering the controlled dose release element according to the present invention to the animal. The first active substance is typically used to treat a sick or infected ruminant, or to prevent its disease, or it can be used for both purposes, or it can be used to change the physiological status of the ruminant. HE
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPR8390A AUPR839001A0 (en) | 2001-10-19 | 2001-10-19 | Dosage form, device and methods of treatment |
PCT/AU2002/001426 WO2003033031A1 (en) | 2001-10-19 | 2002-10-18 | Dosage form, device and methods of treatment |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP0401808A2 true HUP0401808A2 (en) | 2005-01-28 |
HUP0401808A3 HUP0401808A3 (en) | 2005-11-28 |
Family
ID=3832213
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0401808A HUP0401808A3 (en) | 2001-10-19 | 2002-10-18 | Dosage forms, devices and methods of treatment |
Country Status (22)
Country | Link |
---|---|
US (1) | US20050064032A1 (en) |
EP (1) | EP1448151A4 (en) |
JP (1) | JP2005510485A (en) |
KR (1) | KR20050037410A (en) |
CN (1) | CN1571663A (en) |
AR (1) | AR037116A1 (en) |
AU (5) | AUPR839001A0 (en) |
BR (1) | BR0212975A (en) |
CA (1) | CA2463674A1 (en) |
CR (1) | CR7312A (en) |
EA (1) | EA005778B1 (en) |
EC (1) | ECSP045063A (en) |
HR (1) | HRP20040231A2 (en) |
HU (1) | HUP0401808A3 (en) |
IL (1) | IL160754A0 (en) |
MX (1) | MXPA04003679A (en) |
NO (1) | NO20041941L (en) |
NZ (1) | NZ531672A (en) |
PE (1) | PE20030519A1 (en) |
PL (1) | PL368387A1 (en) |
WO (1) | WO2003033031A1 (en) |
ZA (1) | ZA200403743B (en) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITRN20030021A1 (en) * | 2003-07-21 | 2005-01-22 | Ascor Chimici Srl | COMPOSITION OF MATERING INCLUDING PARTICLES CONTAINING CHOLINE CHLORIDE TO BE ADMINISTERED IN RUMINALLY PROTECTED AND POST-RUMINALLY EFFECTIVE FORM. |
ITMI20041820A1 (en) * | 2004-09-24 | 2004-12-24 | Ascor Chimici Srl | COMPOSITION IN MICRO-PELLETS WITH CONTROLLED RELEASE OF PHYSIOLOGICALLY ACTIVE SUBSTANCES, PREPARATION PROCEDURE AND RELATED USE IN THE ZOOTECHNICAL SECTOR. |
US20090208579A1 (en) * | 2004-12-27 | 2009-08-20 | Eisai R & D Management Co., Ltd. | Matrix Type Sustained-Release Preparation Containing Basic Drug or Salt Thereof, and Method for Manufacturing the Same |
US20060280789A1 (en) * | 2004-12-27 | 2006-12-14 | Eisai Research Institute | Sustained release formulations |
AU2005320547B2 (en) * | 2004-12-27 | 2009-02-05 | Eisai R & D Management Co., Ltd. | Method for stabilizing anti-dementia drug |
US20060246003A1 (en) * | 2004-12-27 | 2006-11-02 | Eisai Co. Ltd. | Composition containing anti-dementia drug |
NZ554260A (en) * | 2007-09-30 | 2010-05-28 | Agres Ltd | Selenomethionine andor selenocysteine administration to non-human animals to increase selenium content in protein sources |
WO2010126857A1 (en) * | 2009-04-28 | 2010-11-04 | Wyeth Llc | Parasiticidal combinations of macrocyclic lactones and polyether antibiotics |
AU2014203209B2 (en) * | 2009-07-31 | 2015-11-26 | Boehringer Ingelheim Animal Health USA Inc. | Sustained release capsules |
ES2752923T3 (en) * | 2009-07-31 | 2020-04-06 | Boehringer Ingelheim Animal Health Usa Inc | Extended-release capsules |
EP2512467A1 (en) * | 2009-12-17 | 2012-10-24 | Merial Limited | Compositions comprising macrocyclic lactone compounds and spirodioxepinoindoles |
FR2992219B1 (en) * | 2012-06-22 | 2014-07-11 | Aditec Lab | COMPOSITION FOR THE TREATMENT OF HYPOCALCAEMIA IN RUMINANTS |
EP3164117B1 (en) | 2014-07-03 | 2023-09-06 | SpecGx LLC | Abuse deterrent immediate release formulations comprising non-cellulose polysaccharides |
US11065246B2 (en) | 2016-02-08 | 2021-07-20 | SpecGx LLC | Glucomannan containing pharmaceutical compositions with extended release and abuse deterrent properties |
US10737079B2 (en) * | 2016-12-02 | 2020-08-11 | Clexio Biosciences Ltd. | Gastric residence system |
AU2018292285B2 (en) * | 2017-06-26 | 2023-05-25 | Boehringer Ingelheim Animal Health USA Inc. | Dual active parasiticidal granule compositions, methods and uses thereof |
CA189878S (en) | 2017-08-25 | 2021-02-18 | Argenta Mfg Limited | Intraruminal device |
BR112021004458A2 (en) * | 2018-09-10 | 2021-05-25 | Argenta Innovation Limited | controlled release formulations in delivery devices |
BR112021004523A2 (en) * | 2018-09-10 | 2021-06-08 | Argenta Innovation Limited | formulations for sustained release in administration devices |
WO2020068510A1 (en) | 2018-09-25 | 2020-04-02 | SpecGx LLC | Abuse deterrent immediate release capsule dosage forms |
FI4013348T3 (en) * | 2019-08-14 | 2024-03-15 | Elanco Tiergesundheit Ag | New wing protector for winged capsule and method of using same |
BR112022014865A2 (en) * | 2020-02-07 | 2022-09-20 | Elanco Animal Health Incorporated | WINGED CAPSULE |
WO2021242481A1 (en) * | 2020-05-28 | 2021-12-02 | Boehringer Ingelheim Animal Health USA Inc. | Bi-modal release intra-ruminal capsule device and methods of use thereof |
DK4037666T3 (en) | 2020-12-08 | 2024-06-24 | Ruminant Biotech Corp Ltd | IMPROVEMENT OF DEVICES AND METHODS FOR ADMINISTERING SUBSTANCES TO ANIMALS |
CN113398337A (en) * | 2021-06-23 | 2021-09-17 | 上海市肺科医院 | Spinal internal fixation device containing artificial bone carrier implanted with antituberculosis drugs in sustained release manner |
Family Cites Families (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU520409B2 (en) * | 1977-05-25 | 1982-01-28 | Commonwealth Scientific And Industrial Research Organisation | Controlled release composition |
GB2077586A (en) * | 1980-06-12 | 1981-12-23 | Standard Telephones Cables Ltd | Sustained-release device |
NZ197543A (en) * | 1980-07-02 | 1984-12-14 | Commw Scient Ind Res Org | Controlled release compositions for inclusion in intraruminal devices |
US4416659A (en) * | 1981-11-09 | 1983-11-22 | Eli Lilly And Company | Sustained release capsule for ruminants |
NZ203203A (en) * | 1982-02-16 | 1985-09-13 | Commw Scient Ind Res Org | Controlled release device:gas diffusion limited |
IE54171B1 (en) * | 1982-06-22 | 1989-07-05 | Univ Glasgow | Device for introducing nutrients and/or therapeutic materials into ruminant animals |
GB8328916D0 (en) * | 1983-10-28 | 1983-11-30 | Castex Prod | Pharmaceutical pellet |
US4777049A (en) * | 1983-12-01 | 1988-10-11 | Alza Corporation | Constant release system with pulsed release |
NZ212100A (en) * | 1984-06-02 | 1988-07-28 | Castex Prod | Rumen bolus; outer casing sheds in segments |
US4723958A (en) * | 1986-05-23 | 1988-02-09 | Merck & Co., Inc. | Pulsatile drug delivery system |
US4867980A (en) * | 1986-10-10 | 1989-09-19 | Coopers Animal Health Australia Limited | Heavy density depot |
US5391381A (en) * | 1987-06-25 | 1995-02-21 | Alza Corporation | Dispenser capable of delivering plurality of drug units |
US5938654A (en) * | 1987-06-25 | 1999-08-17 | Alza Corporation | Osmotic device for delayed delivery of agent |
US4957494A (en) * | 1987-06-25 | 1990-09-18 | Alza Corporation | Multi-layer delivery system |
US5110597A (en) * | 1987-06-25 | 1992-05-05 | Alza Corporation | Multi-unit delivery system |
US4874388A (en) * | 1987-06-25 | 1989-10-17 | Alza Corporation | Multi-layer delivery system |
US5023088A (en) * | 1987-06-25 | 1991-06-11 | Alza Corporation | Multi-unit delivery system |
US4915949A (en) * | 1987-07-13 | 1990-04-10 | Alza Corporation | Dispenser with movable matrix comprising a plurality of tiny pills |
GB8829089D0 (en) * | 1988-12-13 | 1989-01-25 | Coopers Animal Health | Intra ruminal device |
DE59000232D1 (en) * | 1989-02-11 | 1992-09-10 | Bayer Ag | MEDICINAL PRODUCTS WITH CONTROLLED DELIVERY OF ACTIVE SUBSTANCES. |
US5110598A (en) * | 1989-06-30 | 1992-05-05 | Smithkline Beecham Corp. | Intermittent release dosage form |
US5126142A (en) * | 1989-07-18 | 1992-06-30 | Alza Corporation | Dispenser comprising ionophore |
US5017381A (en) * | 1990-05-02 | 1991-05-21 | Alza Corporation | Multi-unit pulsatile delivery system |
MX9200339A (en) * | 1991-01-28 | 1992-08-01 | Hoechst Ag | PREPARED FOR THE CONTROLLED RELEASE OF ACTIVE SUBSTANCES, WHICH ARE APPROPRIATE AS THERAPEUTICS OR TO IMPROVE THE GROWTH AND USE OF FEED IN RUMINANTS |
US5417682A (en) * | 1991-01-30 | 1995-05-23 | Alza Corporation | Device for administering active agent to biological environment |
AU650113B2 (en) * | 1991-04-05 | 1994-06-09 | Eli Lilly And Company | Sustained release capsule and formulations |
US5240713A (en) * | 1991-09-27 | 1993-08-31 | Alza Corporation | Dual rate agent delivery device |
US5221278A (en) * | 1992-03-12 | 1993-06-22 | Alza Corporation | Osmotically driven delivery device with expandable orifice for pulsatile delivery effect |
WO1995019763A1 (en) * | 1994-01-20 | 1995-07-27 | New Zealand Pastorial Agriculture Research Institute Limited | Device for administration of beneficial materials to ruminants |
AUPM897594A0 (en) * | 1994-10-25 | 1994-11-17 | Daratech Pty Ltd | Controlled release container |
EP1126826B3 (en) * | 1998-11-02 | 2019-05-15 | Alkermes Pharma Ireland Limited | Multiparticulate modified release composition of methylphenidate |
US6569857B1 (en) * | 1999-05-03 | 2003-05-27 | Drugtech Corporation | Dietary supplement |
DE19956486A1 (en) * | 1999-11-24 | 2001-06-21 | Lohmann Therapie Syst Lts | Multi-layer preparation for the controlled, pulsed delivery of active ingredients |
CA2395892C (en) * | 1999-12-31 | 2014-06-03 | Rutgers, The State University | Pharmaceutical formulation composed of a polymer blend and an active compound for time-controlled release |
AU2001237424A1 (en) * | 2000-02-28 | 2001-09-12 | Akzo Nobel N.V. | Bodies for the controlled release of active substances |
-
2001
- 2001-10-19 AU AUPR8390A patent/AUPR839001A0/en not_active Abandoned
-
2002
- 2002-10-17 PE PE2002001028A patent/PE20030519A1/en not_active Application Discontinuation
- 2002-10-18 IL IL16075402A patent/IL160754A0/en unknown
- 2002-10-18 AU AU2002332975A patent/AU2002332975C1/en not_active Expired
- 2002-10-18 PL PL02368387A patent/PL368387A1/en not_active Application Discontinuation
- 2002-10-18 WO PCT/AU2002/001426 patent/WO2003033031A1/en active Application Filing
- 2002-10-18 AR ARP020103936A patent/AR037116A1/en unknown
- 2002-10-18 CN CNA028207009A patent/CN1571663A/en active Pending
- 2002-10-18 KR KR1020047005590A patent/KR20050037410A/en not_active Application Discontinuation
- 2002-10-18 US US10/490,975 patent/US20050064032A1/en not_active Abandoned
- 2002-10-18 CA CA002463674A patent/CA2463674A1/en not_active Abandoned
- 2002-10-18 NZ NZ531672A patent/NZ531672A/en not_active IP Right Cessation
- 2002-10-18 MX MXPA04003679A patent/MXPA04003679A/en active IP Right Grant
- 2002-10-18 HU HU0401808A patent/HUP0401808A3/en unknown
- 2002-10-18 EA EA200400557A patent/EA005778B1/en not_active IP Right Cessation
- 2002-10-18 JP JP2003535833A patent/JP2005510485A/en active Pending
- 2002-10-18 EP EP02801251A patent/EP1448151A4/en not_active Withdrawn
- 2002-10-18 BR BR0212975-2A patent/BR0212975A/en not_active IP Right Cessation
-
2004
- 2004-03-09 HR HR20040231A patent/HRP20040231A2/en not_active Application Discontinuation
- 2004-04-15 EC EC2004005063A patent/ECSP045063A/en unknown
- 2004-04-16 CR CR7312A patent/CR7312A/en unknown
- 2004-05-10 NO NO20041941A patent/NO20041941L/en not_active Application Discontinuation
- 2004-05-14 ZA ZA200403743A patent/ZA200403743B/en unknown
- 2004-09-09 AU AU2004210542A patent/AU2004210542C1/en not_active Expired
-
2005
- 2005-10-28 AU AU2005227413A patent/AU2005227413A1/en not_active Abandoned
-
2009
- 2009-12-16 AU AU2009250987A patent/AU2009250987A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
IL160754A0 (en) | 2004-08-31 |
MXPA04003679A (en) | 2004-07-23 |
AU2009250987A1 (en) | 2010-01-14 |
CA2463674A1 (en) | 2003-04-24 |
US20050064032A1 (en) | 2005-03-24 |
PE20030519A1 (en) | 2003-06-13 |
AU2002332975B2 (en) | 2005-02-03 |
EP1448151A4 (en) | 2010-01-13 |
KR20050037410A (en) | 2005-04-21 |
AU2004210542B9 (en) | 2005-09-01 |
HRP20040231A2 (en) | 2004-08-31 |
NZ531672A (en) | 2006-08-31 |
CN1571663A (en) | 2005-01-26 |
AUPR839001A0 (en) | 2001-11-15 |
PL368387A1 (en) | 2005-03-21 |
AU2004210542B2 (en) | 2005-07-28 |
HUP0401808A3 (en) | 2005-11-28 |
AU2002332975B9 (en) | 2005-03-17 |
BR0212975A (en) | 2004-10-13 |
AU2005227413A1 (en) | 2005-11-17 |
EP1448151A1 (en) | 2004-08-25 |
AU2002332975C1 (en) | 2009-01-29 |
AU2004210542C1 (en) | 2009-01-08 |
CR7312A (en) | 2004-10-27 |
EA005778B1 (en) | 2005-06-30 |
AU2004210542A1 (en) | 2004-09-30 |
JP2005510485A (en) | 2005-04-21 |
ECSP045063A (en) | 2004-05-28 |
AR037116A1 (en) | 2004-10-20 |
WO2003033031A1 (en) | 2003-04-24 |
ZA200403743B (en) | 2005-05-16 |
NO20041941L (en) | 2004-05-10 |
EA200400557A1 (en) | 2005-02-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0401808A2 (en) | Dosage forms, devices and methods of treatment | |
Parisi et al. | Recurrent intraoral pyogenic granuloma with satellitosis treated with corticosteroids | |
RU95109905A (en) | Liquid, semisolid, solid, gel-like or paste-like compositions and a method of mouth cavity disease treatment | |
DK0759757T3 (en) | Oral, liquid alendronate formulations | |
Godfrey et al. | A randomized clinical trial on the treatment of oral herpes with topical zinc oxide/glycine | |
CY1115766T1 (en) | CLEANING AND STABILIZATION OF Peptide and Protein in Pharmaceutical Agents | |
HUP0102899A2 (en) | Process for preparation of compositions for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds, to the lower respiratory tract | |
BRPI0513200A (en) | use of an anti-igf-1r antibody in the preparation of a medicament for combined treatment for nonhematological malignancies | |
AR045956A1 (en) | MULTIPARTICLES OF PANTOPRAZOL AND FORMULATION CONTAINING THEM | |
McComas et al. | Increasing compliance with medical procedures: Application of the high‐probability request procedure to a toddler | |
DE69116380D1 (en) | PHARMACEUTICAL PREPARATION FOR TREATING EXTENDED COAGLING TIME | |
FI3749308T3 (en) | Treatment of patients with classic fabry disease with migalastat | |
Park et al. | Modified titanium implant as a gateway to the human body: the implant mediated drug delivery system | |
Nishikawa et al. | Healing of digital dermatitis after a single treatment with topical oxytetracycline in 89 dairy cows | |
Borges et al. | Calcitonin: a non-invasive giant cells therapy | |
Jorgensen et al. | The ins and outs of periodontal antimicrobial therapy | |
RU2297233C1 (en) | Method for treating glossalgia cases | |
Stefos et al. | Managing vomiting in the third trimester of pregnancy during fixed prosthodontic treatment. A case report and review of the literature | |
DE68916651D1 (en) | MEDICINES FOR TREATING TOXOPLASMOSIS. | |
Van Dyck et al. | Nutrition in the ICU: sometimes route does matter | |
ATE107504T1 (en) | MEDICATIONS FOR THE TREATMENT OF CRYPTOSPORIDIOSIS. | |
JPS6411619B2 (en) | ||
FR2786699B1 (en) | MEDICINE, IN PARTICULAR FOR PREVENTING OR TREATING SEXUAL DYSFUNCTIONS | |
Rubinstein | Postprandial drowsiness | |
Rout et al. | Advances in Local Anesthesia and Pain Management for Practicing Dentists: A Comprehensive Review |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD9A | Lapse of provisional protection due to non-payment of fees |